🔎 Trials Near Me

Akèy › Maladi selil fòs › Michigan

Etid klinik pou Maladi selil fòs nan Michigan

9 etid pou Maladi selil fòs ap chèche patisipan nan sit nan Michigan.

Vil nan Michigan

Tèks ofisyèl etid la (Anglè)

A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)

  • The Cancer and Hematology Centers (CHC), Grand Rapids
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07656415

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  • Children's Hospital of Michigan, Detroit
  • Great Lakes Research Institute, Flourish Detroit, Southfield
Ap rekriteFaz 2/3
Laj 12 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Central Michigan Children's Hospital of Michigan, Detroit
  • Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • Detroit Medical Center, Detroit
  • Henry Ford Health System, Detroit
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT06699849

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • University of Michigan Health System - Ann Arbor- Site Number : 8400035, Ann Arbor
Ap rekriteFaz 3
Laj 10 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT06975865

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

  • Helen DeVos Children's Hospital, Grand Rapids
Ap rekriteFaz 1/2
1 Day – 21 Years · Tout sèks · Mizajou May 29, 2026 · NCT03128996

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • Henry Ford Cancer Center, Detroit
Ap rekriteEtid obsèvasyon
Laj 14 a 37 · Tout sèks · Mizajou Jan 28, 2026 · NCT07373639

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • The Regents of the University of Michigan, Ann Arbor
Ap rekrite
Laj 16 a 30 · Tout sèks · Mizajou Jan 7, 2026 · NCT06374238

HPC Offered for PRESERVE Expansion

  • Henry Ford Health, Detroit
Ap rekriteEtid obsèvasyon
Laj 12 a 80 · Tout sèks · Mizajou Aug 28, 2025 · NCT07145411

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.